vs
Side-by-side financial comparison of Dexcom (DXCM) and JANUS HENDERSON GROUP PLC (JHG). Click either name above to swap in a different company.
Dexcom is the larger business by last-quarter revenue ($1.3B vs $1.1B, roughly 1.1× JANUS HENDERSON GROUP PLC). JANUS HENDERSON GROUP PLC runs the higher net margin — 35.3% vs 21.2%, a 14.1% gap on every dollar of revenue. On growth, JANUS HENDERSON GROUP PLC posted the faster year-over-year revenue change (61.3% vs 21.6%). Over the past eight quarters, JANUS HENDERSON GROUP PLC's revenue compounded faster (43.9% CAGR vs 12.0%).
Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.
Janus Henderson is a British-American global asset management group headquartered in the City of London, United Kingdom. It offers a range of financial products to individuals, intermediary advisors, and institutional investors globally under the trade name Janus Henderson Investors.
DXCM vs JHG — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.3B | $1.1B |
| Net Profit | $267.3M | $403.2M |
| Gross Margin | 62.9% | — |
| Operating Margin | 25.6% | 42.7% |
| Net Margin | 21.2% | 35.3% |
| Revenue YoY | 21.6% | 61.3% |
| Net Profit YoY | 153.6% | 231.0% |
| EPS (diluted) | $0.67 | $2.59 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.3B | — | ||
| Q4 25 | $1.3B | $1.1B | ||
| Q3 25 | $1.2B | $700.4M | ||
| Q2 25 | $1.2B | $633.2M | ||
| Q1 25 | $1.0B | $621.4M | ||
| Q4 24 | $1.1B | $708.3M | ||
| Q3 24 | $994.2M | $624.8M | ||
| Q2 24 | $1.0B | $588.4M |
| Q1 26 | $267.3M | — | ||
| Q4 25 | $267.3M | $403.2M | ||
| Q3 25 | $283.8M | $142.1M | ||
| Q2 25 | $179.8M | $149.9M | ||
| Q1 25 | $105.4M | $120.7M | ||
| Q4 24 | $151.7M | $121.8M | ||
| Q3 24 | $134.6M | $27.3M | ||
| Q2 24 | $143.5M | $129.7M |
| Q1 26 | 62.9% | — | ||
| Q4 25 | 62.9% | — | ||
| Q3 25 | 60.5% | — | ||
| Q2 25 | 59.5% | — | ||
| Q1 25 | 56.9% | — | ||
| Q4 24 | 58.9% | — | ||
| Q3 24 | 59.7% | — | ||
| Q2 24 | 62.4% | — |
| Q1 26 | 25.6% | — | ||
| Q4 25 | 25.6% | 42.7% | ||
| Q3 25 | 20.1% | 24.6% | ||
| Q2 25 | 18.4% | 25.9% | ||
| Q1 25 | 12.9% | 24.7% | ||
| Q4 24 | 17.0% | 27.9% | ||
| Q3 24 | 15.3% | 26.4% | ||
| Q2 24 | 15.7% | 27.9% |
| Q1 26 | 21.2% | — | ||
| Q4 25 | 21.2% | 35.3% | ||
| Q3 25 | 23.5% | 20.3% | ||
| Q2 25 | 15.5% | 23.7% | ||
| Q1 25 | 10.2% | 19.4% | ||
| Q4 24 | 13.6% | 17.2% | ||
| Q3 24 | 13.5% | 4.4% | ||
| Q2 24 | 14.3% | 22.0% |
| Q1 26 | $0.67 | — | ||
| Q4 25 | $0.67 | $2.59 | ||
| Q3 25 | $0.70 | $0.92 | ||
| Q2 25 | $0.45 | $0.95 | ||
| Q1 25 | $0.27 | $0.77 | ||
| Q4 24 | $0.37 | $0.77 | ||
| Q3 24 | $0.34 | $0.17 | ||
| Q2 24 | $0.35 | $0.81 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $917.7M | $1.6B |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $2.7B | $5.1B |
| Total Assets | $6.3B | $8.3B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $917.7M | — | ||
| Q4 25 | $917.7M | $1.6B | ||
| Q3 25 | $1.8B | $1.4B | ||
| Q2 25 | $1.2B | $1.3B | ||
| Q1 25 | $904.9M | $1.4B | ||
| Q4 24 | $606.1M | $1.6B | ||
| Q3 24 | $621.2M | $1.8B | ||
| Q2 24 | $939.2M | $1.3B |
| Q1 26 | $2.7B | — | ||
| Q4 25 | $2.7B | $5.1B | ||
| Q3 25 | $2.7B | $4.8B | ||
| Q2 25 | $2.6B | $4.8B | ||
| Q1 25 | $2.3B | $4.7B | ||
| Q4 24 | $2.1B | $4.6B | ||
| Q3 24 | $2.0B | $4.6B | ||
| Q2 24 | $2.4B | $4.5B |
| Q1 26 | $6.3B | — | ||
| Q4 25 | $6.3B | $8.3B | ||
| Q3 25 | $7.5B | $7.6B | ||
| Q2 25 | $7.3B | $7.5B | ||
| Q1 25 | $6.8B | $7.1B | ||
| Q4 24 | $6.5B | $7.0B | ||
| Q3 24 | $6.4B | $7.3B | ||
| Q2 24 | $6.8B | $6.4B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $322.7M |
| Free Cash FlowOCF − Capex | — | $320.4M |
| FCF MarginFCF / Revenue | — | 28.0% |
| Capex IntensityCapex / Revenue | — | 0.2% |
| Cash ConversionOCF / Net Profit | — | 0.80× |
| TTM Free Cash FlowTrailing 4 quarters | — | $710.9M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $294.0M | $322.7M | ||
| Q3 25 | $659.9M | $258.8M | ||
| Q2 25 | $303.0M | $135.2M | ||
| Q1 25 | $183.8M | $2.8M | ||
| Q4 24 | $301.4M | $247.3M | ||
| Q3 24 | $199.5M | $228.5M | ||
| Q2 24 | $279.4M | $223.8M |
| Q1 26 | — | — | ||
| Q4 25 | $192.1M | $320.4M | ||
| Q3 25 | $579.4M | $256.4M | ||
| Q2 25 | $208.9M | $133.2M | ||
| Q1 25 | $96.8M | $900.0K | ||
| Q4 24 | $176.8M | $243.5M | ||
| Q3 24 | $88.3M | $225.9M | ||
| Q2 24 | $213.3M | $221.9M |
| Q1 26 | — | — | ||
| Q4 25 | 15.3% | 28.0% | ||
| Q3 25 | 47.9% | 36.6% | ||
| Q2 25 | 18.1% | 21.0% | ||
| Q1 25 | 9.3% | 0.1% | ||
| Q4 24 | 15.9% | 34.4% | ||
| Q3 24 | 8.9% | 36.2% | ||
| Q2 24 | 21.2% | 37.7% |
| Q1 26 | — | — | ||
| Q4 25 | 8.1% | 0.2% | ||
| Q3 25 | 6.7% | 0.3% | ||
| Q2 25 | 8.1% | 0.3% | ||
| Q1 25 | 8.4% | 0.3% | ||
| Q4 24 | 11.2% | 0.5% | ||
| Q3 24 | 11.2% | 0.4% | ||
| Q2 24 | 6.6% | 0.3% |
| Q1 26 | — | — | ||
| Q4 25 | 1.10× | 0.80× | ||
| Q3 25 | 2.33× | 1.82× | ||
| Q2 25 | 1.69× | 0.90× | ||
| Q1 25 | 1.74× | 0.02× | ||
| Q4 24 | 1.99× | 2.03× | ||
| Q3 24 | 1.48× | 8.37× | ||
| Q2 24 | 1.95× | 1.73× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DXCM
Segment breakdown not available.
JHG
| Investment Advice | $585.2M | 51% |
| Investment Performance | $425.8M | 37% |
| Other | $76.4M | 7% |
